Confidence region approach for assessing bioequivalence and biosimilarity accounting for heterogeneity of variability
10.1155/2015/298647
Saved in:
Main Authors: | Li, J, Chow, S.-C |
---|---|
Other Authors: | DUKE-NUS MEDICAL SCHOOL |
Format: | Article |
Published: |
2020
|
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/180922 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Statistical considerations in biosimilar assessment using biosimilarity index
by: Zhang, A, et al.
Published: (2020) -
On the regulatory approval pathway of biosimilar products
by: Wang, J, et al.
Published: (2020) -
Empirical likelihood confidence region for parameter in the errors-in-variables models
by: Cui, H., et al.
Published: (2014) -
In vivo and in vitro bioequivalence testing
by: Lu, Y, et al.
Published: (2020) -
Efficacy and safety of rituximab biosimilar in refractory lupus
by: Nantakarn Pongtarakulpanit, et al.
Published: (2020)